Day

May 11, 2020

11
May
2020

Science in Plain English for the Pandemic

Art Krieg is one of the leaders in the field of oligonucleotide drug discovery, going back to the 1980s. Today, he’s the founder and chief scientific officer of Cambridge, Mass.-based Checkmate Pharmaceuticals, a cancer immunotherapy company. It’s his job to explain scientific concepts to a variety of professional audiences. But he leveraged that skill recently to do an interesting thing...
Read More